IP Library Granted Patent US 12,343,084
Granted Patent B2
US 12,343,084 · App. 17/383,327 · Granted Jul 1, 2025

Systems and methods for predicting thrombosis for heart valve replacements

Inventors: Lakshmi Prasad Dasi (Dublin, OH); Amirsepehr Azimian (Columbus, OH); Hoda Hatoum (Atlanta, GA); Shelly Singh-Gryzbon (Atlanta, GA); Vinod Thourani (Atlanta, GA); Ajit Yoganathan (Atlanta, GA)
Assignees: Ohio State Innovation Foundation; Georgia Tech Research Corporation
A61B34/10A61F2/24G06T7/0012G16H30/20G16H30/40G16H50/20G16H50/30A61B2034/104G06T2207/20081G06T2207/20084G06T2207/30048G16H10/60G16H20/40
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,343,084
App. No.
17/383,327
Granted
Jul 1, 2025
Kind
B2
Abstract

Methods for determining likelihood of thrombosis based on patient-specific anatomic, valve, and flow parameters are disclosed herein. Such methods are used to select a transcatheter aortic valve that decreases likelihood of thrombosis after TAVR procedures. The methods correlate a number of fluid flow and geometric parameters such as stasis volume, neo-sinus volume, kinematic viscosity, dynamic viscosity, heart rate, the circulation, ejection time, velocity of the main jet, wall shear stress, total kinetic energy in the neo sinus volume, width of the neo-sinus, height or depth of the neo-sinus, the angle between the velocity direction and the stent of the transcatheter valve, the distance from the tip of the leaflet perpendicular to the leaflet edge and intersecting the sinotubular junction, and the cross-sectional area of the neo-sinus taken from a longitudinal or axial perspective. Such parameters are used to derive empirical or semi-empirical mathematical models to determine the likelihood of thrombosis.

Claims (46)

1. A method for predicting the development of thrombosis for a patient planning on receiving a heart valve replacement, the method comprising:

executing, by at least a processor, program code stored in a non-transitory computer-readable-medium to perform a simulation, comprising:

gathering image data representing one or more anatomical parameters of a region of a heart of a patient, wherein the image data comprises three-dimensional shapes of the region of the patient's heart;

obtaining one or more flow parameters based on fluid dynamic simulations of blood flow through the region of the patient's heart comprising a neo-sinus area;

and

using a computational model to quantify a risk that patient will develop thrombosis upon implantation of the heart valve replacement in the patient, wherein the computational model comprises a mathematical equation r norm ˜V·d·cosθ·Ratio˜V·d·cosθ·A NS /A separated representing a fraction of circulation influx into the neo-sinus area based on the one or more anatomical and flow parameters, wherein V is a velocity of a main jet, d is a distance from a tip of a leaflet perpendicular to a leaflet edge and intersecting a sinotubular junction, θ is an angle between a velocity direction and a stent of the heart valve, A NS is a ratio of an area of a neo-sinus opening, T ej is an ejection time, A separated is a separated area, and A c is a cross-sectional area of the neo-sinus taken from a longitudinal or axial perspective.

2. The method of claim 1 , wherein the computational model further comprises numerical simulation comprising computational fluid dynamics, fluid structure interaction models.

3. The method of claim 1 , wherein the computational model further comprises a trained artificial intelligence neural network to determine a likelihood of thrombosis based on the fraction of circulation influx into the neo-sinus area based on the one or more anatomical and flow parameters.

4. The method of claim 1 , wherein the computational model further comprises a machine learning algorithm to obtain the one or more anatomical parameters and the one or more flow parameters.

5. A computer implemented method to evaluate a risk of development of thrombosis for a patient planning on receiving a heart valve implantation, the method comprising:

executing, by at least a processor, program code stored in a non-transitory computer-readable-medium to perform a simulation, comprising:

gathering image data representing one or more anatomical and hemodynamic parameters of a region of a heart of the patient prior to receiving the heart valve implantation, wherein the image data comprises three-dimensional shapes of the region of the patient's heart;

simulating a post-deployment anatomy of the patient's heart corresponding to a selection of the heart valve implantation, based on the image data; and

using a mathematical model to calculate one or more quantities that correlate to the risk of the development of thrombosis post-deployment of the heart valve with specified sensitivity and specificity, wherein the mathematical model requires inputs comprising geometrical parameters obtained based on simulated post-deployment anatomy and the image data, and wherein the one or more quantities comprise percent stasis volumes during systole and during diastole.

6. The computer-implemented method of claim 5 , wherein the image data comprise X-ray imaging data, computed tomography imaging data, magnetic resonance imaging data, and/or ultrasound imaging data.

7. The computer-implemented method of claim 5 , wherein the region of the heart comprises a neo-sinus area.

8. The computer-implemented method of claim 5 , wherein the selection of the heart valve implantation comprises one or more of: size of the heart valve implantation, type of the heart valve implantation, positioning of the heart valve implantation comprising a pitch angle, a yaw angle, and/or a depth.

9. The computer-implemented method of claim 5 , wherein the one or more quantities comprise a stasis volume (SV).

10. The computer-implemented method of claim 5 , wherein the one or more quantities comprise a fluid circulation (Γ).

11. The computer-implemented method of claim 5 , wherein the one or more quantities comprise a total kinetic energy (KE) defined over a neo-sinus volume.

12. The computer-implemented method of claim 5 , wherein the one or more quantities comprise an average wall shear stress (WSS) for near wall stagnation defined over a neo-sinus volume.

13. The computer-implemented method of claim 5 , wherein the one or more quantities comprise a normalized fluid circulation parameter (Γ norm ).

14. The computer-implemented method of claim 5 , wherein the mathematical model is an empirical or a semi-empirical mathematical model.

15. The computer-implemented method of claim 5 , wherein the inputs comprise a neo-sinus volume (NSV), a kinematic viscosity (γ), a dynamic viscosity (μ), a heart rate (HR); an ejection time (T ej ), a velocity of a main jet (V), a width of each of a neo-sinus (w), a height or depth of each neo-sinus (h), an angle between a velocity direction and a stent of a transcatheter valve (Θ), a distance from a tip of a leaflet perpendicular to a leaflet edge and intersecting a sinotubular (STJ) junction (d), a cross-sectional area (A c ), and each of a neo-sinus taken from a longitudinal or axial perspective.

16. The computer-implemented method of claim 15 , further comprising using a trained artificial intelligence model to determine a risk of the development of thrombosis post-deployment of the heart valve based on the inputs.

17. The computer-implemented method of claim 15 , further comprising using a trained machine learning model to determine a risk of the development of thrombosis post-deployment of the heart valve based on the inputs.

18. The computer-implemented method of claim 5 , further comprising using the mathematical model to calculate one or more quantities that correlate to the risk of the development of thrombosis post-deployment of the heart valve with a specified uncertainty.

19. The computer-implemented method of claim 5 , further comprising determining a high risk of the development of thrombosis post-deployment of the heart valve, in response to determining that the calculated one or more quantities are below a cutoff value.

20. A computer implemented method to evaluate a risk of development of thrombosis for a patient planning on receiving a heart valve implantation, the method comprising:

executing, by at least a processor, program code stored in a non-transitory computer-readable-medium to perform a simulation, comprising:

gathering image data representing one or more anatomical and hemodynamic parameters of a region of a heart of the patient prior to receiving the heart valve implantation, wherein the image data comprises three-dimensional shapes of the region of the patient's heart;

simulating a post-deployment anatomy of the patient's heart corresponding to a selection of the heart valve implantation, based on the image data; and

using a mathematical model to calculate one or more quantities that correlate to the risk of the development of thrombosis post-deployment of the heart valve with specified sensitivity and specificity, wherein the mathematical model requires inputs comprising geometrical parameters obtained based on simulated post-deployment anatomy and the image data, and wherein the inputs comprise a neo-sinus volume (NSV), a kinematic viscosity (γ), a dynamic viscosity (μ), a heart rate (HR); an ejection time (T ej ), a velocity of a main jet (V), a width of each of a neo-sinus (w), a height or depth of each neo-sinus (h), an angle between a velocity direction and a stent of a transcatheter valve (Θ), a distance from a tip of a leaflet perpendicular to a leaflet edge and intersecting a sinotubular (STJ) junction (d), a cross-sectional area (A c ), and each of a neo-sinus taken from a longitudinal or axial perspective.

21. The computer-implemented method of claim 20 , further comprising using a trained artificial intelligence model to determine a risk of the development of thrombosis post-deployment of the heart valve based on the inputs.

22. The computer-implemented method of claim 20 , further comprising using a trained machine learning model to determine a risk of the development of thrombosis post-deployment of the heart valve based on the inputs.

23. The computer-implemented method of claim 20 , wherein the image data comprise X-ray imaging data, computed tomography imaging data, magnetic resonance imaging data, and/or ultrasound imaging data.

24. The computer-implemented method of claim 20 , wherein the selection of the heart valve implantation comprises one or more of: size of the heart valve implantation, type of the heart valve implantation, positioning of the heart valve implantation comprising a pitch angle, a yaw angle, and/or a depth.

25. The computer-implemented method of claim 20 , wherein the one or more quantities comprise a stasis volume (SV).

26. The computer-implemented method of claim 20 , wherein the one or more quantities comprise a fluid circulation (Γ).

27. The computer-implemented method of claim 20 , wherein the one or more quantities comprise a total kinetic energy (KE) defined over a neo-sinus volume.

28. The computer-implemented method of claim 20 , wherein the one or more quantities comprise an average wall shear stress (WSS) for near wall stagnation defined over a neo-sinus volume.

29. The computer-implemented method of claim 20 , wherein the one or more quantities comprise a normalized fluid circulation parameter (Γ norm ).

30. The computer-implemented method of claim 20 , wherein the one or more quantities comprise percent stasis volumes during systole and during diastole.

31. The computer-implemented method of claim 20 , wherein the mathematical model is an empirical or a semi-empirical mathematical model.

32. The computer-implemented method of claim 20 , further comprising using the mathematical model to calculate one or more quantities that correlate to the risk of the development of thrombosis post-deployment of the heart valve with a specified uncertainty.

33. The computer-implemented method of claim 20 , further comprising determining a high risk of the development of thrombosis post-deployment of the heart valve, in response to determining that the calculated one or more quantities are below a cutoff value.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 7, 2025
From: SINGH-GRYZBON, SHELLY
To: GEORGIA TECH RESEARCH CORPORATION
Reel/Frame 070751/0916 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 7, 2025
From: DASI, LAKSHMI PRASAD; HATOUM, HODA; AZIMIAN, AMIRSEPEHR
To: OHIO STATE INNOVATION FOUNDATION
Reel/Frame 070752/0873 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 7, 2025
From: THOURANI, VINOD
To: PIEDMONT HEALTHCARE, INC.
Reel/Frame 070753/0055 →
Continuity (4)
Continuation In Part 16335614
Provisional Application 63054822 · Jul 22, 2020
Provisional Application 62403940 · Oct 4, 2016
Related Publication 20210346097A1 · Nov 11, 2021
References Cited (40)
US 8908945B2 · Santamaria-Pang · 2014 [cited by applicant]
US 9092743B2 · Singer · 2015 [cited by examiner]
US 20110153286A1 · Zaeuner et al. · 2011 [cited by applicant]
US 20140052241A1 · Harks · 2014 [cited by applicant]
US 20140233818A1 · Thiruvenkadam · 2014 [cited by applicant]
US 20140236292A1 · Braido · 2014 [cited by applicant]
US 20150112659A1 · Mortier · 2015 [cited by applicant]
US 20150178938A1 · Gorman, III · 2015 [cited by applicant]
US 20150370995A1 · Wakai · 2015 [cited by applicant]
US 20160128822A1 · Tejani · 2016 [cited by applicant]
US 20160191887A1 · Casas · 2016 [cited by applicant]
US 20210145361A1 · del Alamo de Pedro · 2021 [cited by examiner]
Madukauwa-David et al. 2020 Ann. Biomed. Engin. 48:169-180 (Year: 2020). [cited by examiner]
Trusty et al. 2019 JACC Cardiovasc. Intervent. 12:1288-1290 (Year: 2019). [cited by examiner]
Vahidkhah et al. 2017 Ann. Thorac. Surg. 104:751-759 (Year: 2017). [cited by examiner]
Wei et al. 2018 Cardiovascular Engineering and Technology 9:289â299 (Year: 2018). [cited by examiner]
Bermejo et al. 2014 Am. J. Physiol. Heart Circ. Physiol. 306:H718-H729 (Year: 2014). [cited by examiner]
Cinar et al. 2018 Journal of Thrombosis and Thrombolysis 45 571-577 (Year: 2018). [cited by examiner]
Singh-Gryzbon et al. 2020 Annals of Biomedical Engineering 48:2400-2411 (Year: 2020). [cited by examiner]
Non-Final Office Action issued in U.S. Appl. No. 17/805,533, dated Jan. 5, 2024. [cited by applicant]
Tribouilloy et al., “Assessment of Severity of Aortic Regurgitation Using the Width of the Vena Contracta a Clinical Color Doppler Imaging Study”, 2000 Circulation 102:558-564. [cited by applicant]
Diamond et al., “Analysis of Probability as an Aid in the Clinical Diagnosis of Coronary-Artery Disease” 1979 New Engl. J. Med. 300:1350-1358. [cited by applicant]
Capelli et al., “Patient-specific simulations of transcatheter aortic valve stent implantation”, 2012 Med. Biol. Eng. Comput. 50:183-192. [cited by applicant]
Pouch et al., “Segmentation of the Aortic Valve Apparatus in 3D Echocardiographic Images: Deformable Modeling of a Branching Medial Structure”, 2015, STACOM 2014 LNCS 8896 pp. 196-203. [cited by applicant]
International Search Report in International Application No. PCT/US17/55046, mailed Jan. 16, 2018, 4 pages. [cited by applicant]
Written Opinion in International Application No. PCT/US17/55046, mailed Jan. 16, 2018, 9 pages. [cited by applicant]
Zheng et al., “Automatic Aorta Segmentation and Valve Landmark Detection in C-Arm CT for Transcatheter Aortic Valve Implantation” IEEE Transactions on Medical Imaging, vol. 31, No. 12, Dec. 2012, pp. 2307-2321, 15 pages. [cited by applicant]
Tribouilloy et al., “Assessment of Severity of Aortic Regurgitation Using the Width of the Vena Contracta”, Circulation 102, 2000, pp. 558-564, 7 pages. [cited by applicant]
Wang et al., “Patient-specific modeling of biomechanical interaction in transcatheter aortic valve deployment”, Journal of Biomechanics 45, 2012, pp. 1965-1971, 7 pages. [cited by applicant]
Extended European Search Report in European Patent Application No. 17874836.4, dated Apr. 8, 2020, 14 pages. [cited by applicant]
Blanke, Philipp et al., “Computed tomography assessment for transcatheter aortic valve in valve implantation: The Vancouver approach to predict anatomical risk for coronary obstruction and other considerations,” Journal… [cited by applicant]
Heitkemper, Megan et al., “Modeling risk of coronary obstruction during transcatheter aortic valve replacement,” The Journal of Thoracic and Cardiovascular Surgery, vol. 159, No. 3, May 18, 2019, 13 pages. [cited by applicant]
Heitkemper, Megan et al., “Simple 2-dimensional anatomic model to predict the risk of coronary obstruction during transcatheter aortic valve replacement,” Journal of Thoracic and Cardiovascular Surgery, Feb. 19, 2020, 1… [cited by applicant]
International Preliminary Report on Patentability in International Application No. PCT/US2017/055046, dated Apr. 9, 2019, 10 pages. [cited by applicant]
Chandran, K.B., “Role of Computational Simulations in Heart Valve Dynamics and Design of Valvular Prostheses,” Mar. 2010, Cardiovascular Engineering and Technology, 1(1), pp. 18-38, 30 pages. [cited by applicant]
Gessat, M. et al., “Image-Based Mechanical Analysis of Stent Deformation: Concept and Exemplary Implementation for Aortic Valve Stents,” Jan. 2014, IEEE Transactions on Biomedical Engineering, vol. 61, No. 1, pp. 4-15, … [cited by applicant]
Keefe, D.F. et al., “A Process for Design, Verification, Validation, and Manufacture of Medical Devices Using Immersive VR Environments,” Nov. 3, 2010, Journal of Medical Devices, vol. 4, 7 pages. [cited by applicant]
Wang, Q. et al., “Patient-Specific Modeling of Biomechanical Interaction in Transcatheter Aortic Valve Deployment,” Jul. 26, 2012, Journal of Biomechanics, 45(11), 19 pages. [cited by applicant]
Blanke et al. 2016 Journal of Cardiovascular Computed Tomography 10:491-499 (Year: 2016). [cited by applicant]
Wang et al., 2012 J. Biomechanics 45: 1965-1971 (Year: 2012). [cited by applicant]